Newsroom
    explainer

    Remote Therapeutic Monitoring and the ActiPatch® Reimbursement Pathway

    How CMS Remote Therapeutic Monitoring (RTM) codes support ActiPatch® deployments in public payer programs.

    ER
    Electrome Reimbursement Team
    Health Economics and Public Payer
    January 28, 2026 1 min read
    Remote Therapeutic Monitoring and the ActiPatch® Reimbursement Pathway

    The PAINKILLER platform is built to support Remote Therapeutic Monitoring (RTM) reimbursement under current CMS guidelines. RTM codes recognize the clinical value of device generated data, patient reported outcomes, and clinician review for non pharmacologic therapies, including bioelectric pain management.

    Why this matters for government payers

    RTM aligned workflows let public payers reimburse evidence backed, non opioid pain management without standing up new code structures. Provider programs receive structured documentation and reporting tools designed to satisfy current RTM billing requirements.

    ER
    Electrome Reimbursement Team
    Health Economics and Public Payer, Electrome
    ActiPatch®
    FDA-cleared ActiPatch® PSWT for musculoskeletal pain.
    For Providers
    Clinician-directed bioelectric therapy programs.
    Back to Newsroom Share this article
    Related

    Keep reading

    ActiPatch® Deployments Inside the U.S. Department of Veterans Affairs

    ActiPatch® Deployments Inside the U.S. Department of Veterans Affairs

    How FDA cleared bioelectric therapy supports VA priorities for non opioid pain management and rehabilitation.